Dômes Pharma Acquires SentrX Animal Care

Zoetis Completes Acquisition of Jurox

September 30, 2022

Pharmaceuticals

Zoetis Inc. has completed its acquisition of Jurox, a privately held Australian animal health company that develops, manufactures and markets veterinary medicines, including the anaesthetic Alfaxan. The deal expands Zoetis' veterinary product portfolio and manufacturing capabilities in Australia and supports greater global distribution of Jurox products.

Swedencare AB (publ) Acquires Animal Pharmaceuticals Inc.

September 24, 2020

Veterinary

Swedencare AB (publ) acquired the operations of US-based Animal Pharmaceuticals Inc. for an initial purchase price of USD 15 million (approx. 131 million SEK) plus a potential earnout of up to USD 10 million; consideration includes cash and a directed new share issue. The deal (closed via newly established US subsidiary Animal Pharm Care USA, Inc.) adds a portfolio of supplements and topical veterinary products sold to ~8,500 US veterinary clinics and positions founder Jason Braun to lead the business and become a major Swedencare shareholder.

Dechra Pharmaceuticals to Acquire Invetx

July 18, 2024

Biotechnology

Dechra Pharmaceuticals Limited has agreed to acquire Boston-based Invetx Inc., a developer of species-specific monoclonal antibody therapeutics for companion animals, for up to $520 million on a cash-free, debt-free basis, subject to customary approvals. The deal gives Dechra access to Invetx's pipeline and half-life extension platform to expand its specialty veterinary biologics capabilities.

Horus Pharma Acquires Significant Stake in Inocare Pharm

November 5, 2024

Medical Devices

Horus Pharma has purchased a significant participation in Inocare Pharm, a Bucharest-based company that commercializes ophthalmic medical devices, diagnostic instruments and dietary supplements. The investment — Horus Pharma's first outside France — is intended to expand Horus's presence into Romania, the Balkans and CIS markets while strengthening Inocare Pharm's product portfolio and market position.

Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners

August 30, 2022

Veterinary

Dechra Pharmaceuticals PLC has completed the acquisition of Med-Pharmex Holdings, Inc. from DW Healthcare Partners. The deal brings a US-based, fully integrated veterinary pharmaceutical manufacturer (Med-Pharmex) into Dechra's global animal-health platform to strengthen its manufacturing capabilities and North American footprint.

Nextmune Acquires VetBiotek

December 22, 2023

Veterinary

Nextmune, a global specialty animal-health company, acquired VetBiotek, a developer of veterinary dermatology topical formulations including MicroSilver BG and Ceramide III products. The acquisition expands Nextmune’s dermatology portfolio and aims to improve production, packaging, distribution and access of VetBiotek’s products to veterinary clinics and distributors.